Prestige Brands announces plan to buy Insight Pharmaceuticals
MLex Summary: Prestige Brands, which markets and distributes healthbare products, has agreed to buy Insight Pharmaceuticals for $750 million. The deal is expected to close in the first half of this fiscal...To view the full article, register now.
Already a subscriber? Click here to view full article